Ireland· IE-PA-PA1077/027/001
Hiberix. Haemophilus Type b (Hib) vaccine.Powder and Solvent for Solution for Injection
A haemophilus influenzae b, kombinationen mit toxoiden product containing haemophilus influenzae type b polysaccharide, registered in Ireland by GlaxoSmithKline (Ireland) Limited. The same ATC class is registered in 2 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Haemophilus influenzae b, kombinationen mit toxoiden is registered in 2 of 19 countries.
Countries holding a registration under ATC J07AG51 (haemophilus influenzae b, kombinationen mit toxoiden), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Haemophilus influenzae b, kombinationen mit toxoiden · ATC J07AG51
2 / 19 countries
- Belgiumprice
- Ireland
The record
At a glance
HPRA (Ireland)- Active substance
- Haemophilus influenzae type b polysaccharide
- Manufacturer
- GlaxoSmithKline (Ireland) Limited
- Country
- Ireland (IE)
- ATC code
- J07AG51
- ATC class
- Haemophilus Influenzae B, Kombinationen mit Toxoiden
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1077/027/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AG51
Haemophilus influenzae b, kombinationen mit toxoiden, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7ab8927d-174d-4497-a6c0-91750d7054ea GET /v1/drugs/7ab8927d-174d-4497-a6c0-91750d7054ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"routes": [
"Intramuscular use"
],
"source": "hpra",
"atc_all": [
"J07AG51"
],
"strength": null,
"pa_number": "PA1077/027/001",
"substances": [
"Haemophilus influenzae type b polysaccharide"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "11/06/1999",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about haemophilus influenzae b, kombinationen mit toxoiden.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.